{"id":797701,"date":"2025-01-03T08:33:29","date_gmt":"2025-01-03T13:33:29","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/neuroone-announces-virtual-investor-webinar-on-january-9-2025-at-1100-a-m-est\/"},"modified":"2025-01-03T08:33:29","modified_gmt":"2025-01-03T13:33:29","slug":"neuroone-announces-virtual-investor-webinar-on-january-9-2025-at-1100-a-m-est","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/neuroone-announces-virtual-investor-webinar-on-january-9-2025-at-1100-a-m-est\/","title":{"rendered":"NeuroOne\u00ae Announces Virtual Investor Webinar on January 9, 2025 at 11:00 a.m. EST"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"center\">\n        <em>Company to Provide Overview of Business Model and Expected Revenue Acceleration in Fiscal Year 2025<\/em>\n      <\/p>\n<p align=\"justify\">\n        <strong>EDEN PRAIRIE, Minn., Jan.  03, 2025  (GLOBE NEWSWIRE) &#8212; <\/strong>NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (&#8220;NeuroOne&#8221; or the &#8220;Company&#8221;), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announced today that it will hold a virtual roadshow webinar to discuss its business operations and recent updates.<\/p>\n<p align=\"justify\">Dave Rosa, Chief Executive Officer of NeuroOne, will provide an overview of the business model and discuss recent milestone achievements, including its recently expanded exclusive distribution agreement with <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=HOQXsAqWysB6AGsogOGaImD4tsVbfKbE9JKvruVfbHTdZI7P4gaMGEeUC7RE1pctZr8iuX1rivq8qW7uMZ7Ly40TE_FwE_mlq7xtnp6ZCE39IWo0x0jCElbPStqOvhGF\" rel=\"nofollow\" target=\"_blank\"><u>Zimmer Biomet<\/u><\/a>, one of the world\u2019s largest medical device manufacturers. Following the Company\u2019s recently announced product revenue growth of 77% to $3.5 million in fiscal year 2024, the Company is expecting product revenue to increase to between $8 and $10 million in fiscal year 2025, representing an increase of between 132% and 190%.<\/p>\n<p align=\"justify\">The webcast will be accompanied by a presentation and followed by a question-and-answer session, which can be accessed via the webcast link or dial-in numbers below.<\/p>\n<p>\n        <strong>Date:<\/strong> Thursday, January 9, 2025<br \/><strong>Time:<\/strong> 11:00 a.m. Eastern Standard Time<br \/><strong>U.S. Dial-In (Toll Free):<\/strong> 877-704-4453<br \/><strong>International Dial-In:<\/strong> 201-389-0920<br \/><strong>Webcast Link:<\/strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=oNmh66aAyatHMtEua7urBah-wdI3CuRJjGdM-WJUu_Tx39eb2tQRULA2pzo5GD6hLHyptZpcXiFluD7-WDPriC5WixELKto2JTLbOHV6ztCNWNRMuUv-Rmr_iWtaVsLgcmEBte_LAlNFdiYoASGDdap0BjSxqB658IYj_5TOql4=\" rel=\"nofollow\" target=\"_blank\"><u>NMTC Virtual Investor Webinar<\/u><\/a><\/p>\n<p align=\"justify\">Please join at least five minutes before the start of the call to ensure timely participation.<\/p>\n<p align=\"justify\">A playback of the call will be available through January 23, 2025. To listen, please call 844-512-2921 within the United States or 412-317-6671 when calling internationally, using replay passcode 13750530.<\/p>\n<p align=\"justify\">\n        <strong>About NeuroOne<\/strong>\n      <\/p>\n<p align=\"justify\">NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson\u2019s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders that may improve patient outcomes and reduce procedural costs. The Company may also pursue applications for other areas such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=yVIbM4hJaxU9F74OnQzv_YzehgqwwEMYcjoA_FHRQQ6IGnUOCZo4CqEg9VFQmf4cFuFUgVo1o-Crh1I4EzHXQuRyvR_gywbXg7uMeZlAY-WqFBlXJC5SPo-JjxSxbV_2D5yEsB05zj5TvU010aBqDQWaSp0pJtiWhLHr3AoflE05m8dYhwv2CtLUgQjuVjL5eAT3p5FJsntLr-M9DMhTkbEkAXP2QYHi2Zq7gWzjwmI=\" rel=\"nofollow\" target=\"_blank\"><u>nmtc1.com<\/u><\/a><u>.<\/u><\/p>\n<p>\n        <strong>Forward Looking Statements<\/strong>\n      <\/p>\n<p align=\"justify\">This press release may include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Except for statements of historical fact, any information contained in this press release may be a forward\u2013looking statement that reflects NeuroOne\u2019s current views about future events and are subject to known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from the information expressed or implied by these forward-looking statements. In some cases, you can identify forward\u2013looking statements by the words or phrases \u201cmay,\u201d \u201cmight,\u201d \u201cwill,\u201d \u201ccould,\u201d \u201cwould,\u201d \u201cshould,\u201d \u201cexpect,\u201d \u201cintend,\u201d \u201cplan,\u201d \u201cforecasts,\u201d \u201cobjective,\u201d \u201canticipate,\u201d \u201cbelieve,\u201d \u201cestimate,\u201d \u201cpredict,\u201d \u201cproject,\u201d \u201cpotential,\u201d \u201ctarget,\u201d \u201cseek,\u201d \u201ccontemplate,\u201d \u201ccontinue, \u201cfocused on,\u201d \u201ccommitted to\u201d and \u201congoing,\u201d or the negative of these terms, or other comparable terminology intended to identify statements about the future. Forward\u2013looking statements may include statements regarding securing a strategic partnership for distribution of the OneRF\u2122 Ablation System, fiscal year 2025 guidance, including expectations for significant product revenue growth and margin expansion, business strategy, market size, potential growth opportunities, future operations, future efficiencies, and other financial and operating information. Although NeuroOne believes that we have a reasonable basis for each forward-looking statement, we caution you that these statements are based on a combination of facts and factors currently known by us and our expectations of the future, about which we cannot be certain. Our actual future results may be materially different from what we expect due to factors largely outside our control, including risks that our strategic partnerships may not facilitate the commercialization or market acceptance of our technology\u037e whether due to supply chain disruptions, labor shortages or otherwise\u037e risks that our technology will not perform as expected based on results of our pre-clinical and clinical trials\u037e risks related to uncertainties associated with the Company\u2019s capital requirements to achieve its business objectives and ability to raise additional funds; the risk that we may not be able to secure or retain coverage or adequate reimbursement for our technology\u037e uncertainties inherent in the development process of our technology\u037e risks related to changes in regulatory requirements or decisions of regulatory authorities\u037e that we may not have accurately estimated the size and growth potential of the markets for our technology\u037e risks relate to clinical trial patient enrollment and the results of clinical trials\u037e that we may be unable to protect our intellectual property rights\u037e and other risks, uncertainties and assumptions, including those described under the heading \u201cRisk Factors\u201d in our filings with the Securities and Exchange Commission. These forward\u2013looking statements speak only as of the date of this press release and NeuroOne undertakes no obligation to revise or update any forward\u2013looking statements for any reason, even if new information becomes available in the future.<\/p>\n<p align=\"justify\">Caution: Federal law restricts this device to sale by or on the order of a physician.<\/p>\n<p>\n        <strong>IR Contact<\/strong><br \/>\n        <br \/>MZ Group \u2013 MZ North America<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8pTTYfvtIBOeUZ3C6Pto2by5BJ4mUSS3b_4UH9SW9yd6rqP_jbN5t0aRddfpDPri6Ct1fThT6WKnxyr0C6gRBw==\" rel=\"nofollow\" target=\"_blank\"><u>NMTC@mzgroup.us<\/u><\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyNjE0MyM2Njc3NTQ0IzUwMDExNDgzNA==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/YjNkMTkwYzItYjc3Mi00NzIxLTgyYTAtZmIzNzIwM2QxNGYzLTUwMDExNDgzNA==\/tiny\/NeuroOne-Medical-Technologies-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Company to Provide Overview of Business Model and Expected Revenue Acceleration in Fiscal Year 2025 EDEN PRAIRIE, Minn., Jan. 03, 2025 (GLOBE NEWSWIRE) &#8212; NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (&#8220;NeuroOne&#8221; or the &#8220;Company&#8221;), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announced today that it will hold a virtual roadshow webinar to discuss its business operations and recent updates. Dave Rosa, Chief Executive Officer of NeuroOne, will provide an overview of the business model and discuss recent milestone achievements, including its recently expanded exclusive distribution agreement with Zimmer Biomet, one of the world\u2019s largest medical device manufacturers. Following the Company\u2019s recently announced product revenue growth of 77% to $3.5 &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/neuroone-announces-virtual-investor-webinar-on-january-9-2025-at-1100-a-m-est\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;NeuroOne\u00ae Announces Virtual Investor Webinar on January 9, 2025 at 11:00 a.m. EST&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-797701","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>NeuroOne\u00ae Announces Virtual Investor Webinar on January 9, 2025 at 11:00 a.m. EST - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/neuroone-announces-virtual-investor-webinar-on-january-9-2025-at-1100-a-m-est\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NeuroOne\u00ae Announces Virtual Investor Webinar on January 9, 2025 at 11:00 a.m. EST - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Company to Provide Overview of Business Model and Expected Revenue Acceleration in Fiscal Year 2025 EDEN PRAIRIE, Minn., Jan. 03, 2025 (GLOBE NEWSWIRE) &#8212; NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (&#8220;NeuroOne&#8221; or the &#8220;Company&#8221;), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announced today that it will hold a virtual roadshow webinar to discuss its business operations and recent updates. Dave Rosa, Chief Executive Officer of NeuroOne, will provide an overview of the business model and discuss recent milestone achievements, including its recently expanded exclusive distribution agreement with Zimmer Biomet, one of the world\u2019s largest medical device manufacturers. Following the Company\u2019s recently announced product revenue growth of 77% to $3.5 &hellip; Continue reading &quot;NeuroOne\u00ae Announces Virtual Investor Webinar on January 9, 2025 at 11:00 a.m. EST&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/neuroone-announces-virtual-investor-webinar-on-january-9-2025-at-1100-a-m-est\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-03T13:33:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyNjE0MyM2Njc3NTQ0IzUwMDExNDgzNA==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuroone-announces-virtual-investor-webinar-on-january-9-2025-at-1100-a-m-est\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuroone-announces-virtual-investor-webinar-on-january-9-2025-at-1100-a-m-est\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"NeuroOne\u00ae Announces Virtual Investor Webinar on January 9, 2025 at 11:00 a.m. EST\",\"datePublished\":\"2025-01-03T13:33:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuroone-announces-virtual-investor-webinar-on-january-9-2025-at-1100-a-m-est\\\/\"},\"wordCount\":841,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuroone-announces-virtual-investor-webinar-on-january-9-2025-at-1100-a-m-est\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMyNjE0MyM2Njc3NTQ0IzUwMDExNDgzNA==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuroone-announces-virtual-investor-webinar-on-january-9-2025-at-1100-a-m-est\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuroone-announces-virtual-investor-webinar-on-january-9-2025-at-1100-a-m-est\\\/\",\"name\":\"NeuroOne\u00ae Announces Virtual Investor Webinar on January 9, 2025 at 11:00 a.m. EST - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuroone-announces-virtual-investor-webinar-on-january-9-2025-at-1100-a-m-est\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuroone-announces-virtual-investor-webinar-on-january-9-2025-at-1100-a-m-est\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMyNjE0MyM2Njc3NTQ0IzUwMDExNDgzNA==\",\"datePublished\":\"2025-01-03T13:33:29+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuroone-announces-virtual-investor-webinar-on-january-9-2025-at-1100-a-m-est\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuroone-announces-virtual-investor-webinar-on-january-9-2025-at-1100-a-m-est\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuroone-announces-virtual-investor-webinar-on-january-9-2025-at-1100-a-m-est\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMyNjE0MyM2Njc3NTQ0IzUwMDExNDgzNA==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMyNjE0MyM2Njc3NTQ0IzUwMDExNDgzNA==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuroone-announces-virtual-investor-webinar-on-january-9-2025-at-1100-a-m-est\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NeuroOne\u00ae Announces Virtual Investor Webinar on January 9, 2025 at 11:00 a.m. EST\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NeuroOne\u00ae Announces Virtual Investor Webinar on January 9, 2025 at 11:00 a.m. EST - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/neuroone-announces-virtual-investor-webinar-on-january-9-2025-at-1100-a-m-est\/","og_locale":"en_US","og_type":"article","og_title":"NeuroOne\u00ae Announces Virtual Investor Webinar on January 9, 2025 at 11:00 a.m. EST - Market Newsdesk","og_description":"Company to Provide Overview of Business Model and Expected Revenue Acceleration in Fiscal Year 2025 EDEN PRAIRIE, Minn., Jan. 03, 2025 (GLOBE NEWSWIRE) &#8212; NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (&#8220;NeuroOne&#8221; or the &#8220;Company&#8221;), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announced today that it will hold a virtual roadshow webinar to discuss its business operations and recent updates. Dave Rosa, Chief Executive Officer of NeuroOne, will provide an overview of the business model and discuss recent milestone achievements, including its recently expanded exclusive distribution agreement with Zimmer Biomet, one of the world\u2019s largest medical device manufacturers. Following the Company\u2019s recently announced product revenue growth of 77% to $3.5 &hellip; Continue reading \"NeuroOne\u00ae Announces Virtual Investor Webinar on January 9, 2025 at 11:00 a.m. EST\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/neuroone-announces-virtual-investor-webinar-on-january-9-2025-at-1100-a-m-est\/","og_site_name":"Market Newsdesk","article_published_time":"2025-01-03T13:33:29+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyNjE0MyM2Njc3NTQ0IzUwMDExNDgzNA==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuroone-announces-virtual-investor-webinar-on-january-9-2025-at-1100-a-m-est\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuroone-announces-virtual-investor-webinar-on-january-9-2025-at-1100-a-m-est\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"NeuroOne\u00ae Announces Virtual Investor Webinar on January 9, 2025 at 11:00 a.m. EST","datePublished":"2025-01-03T13:33:29+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuroone-announces-virtual-investor-webinar-on-january-9-2025-at-1100-a-m-est\/"},"wordCount":841,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuroone-announces-virtual-investor-webinar-on-january-9-2025-at-1100-a-m-est\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyNjE0MyM2Njc3NTQ0IzUwMDExNDgzNA==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuroone-announces-virtual-investor-webinar-on-january-9-2025-at-1100-a-m-est\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/neuroone-announces-virtual-investor-webinar-on-january-9-2025-at-1100-a-m-est\/","name":"NeuroOne\u00ae Announces Virtual Investor Webinar on January 9, 2025 at 11:00 a.m. EST - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuroone-announces-virtual-investor-webinar-on-january-9-2025-at-1100-a-m-est\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuroone-announces-virtual-investor-webinar-on-january-9-2025-at-1100-a-m-est\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyNjE0MyM2Njc3NTQ0IzUwMDExNDgzNA==","datePublished":"2025-01-03T13:33:29+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuroone-announces-virtual-investor-webinar-on-january-9-2025-at-1100-a-m-est\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/neuroone-announces-virtual-investor-webinar-on-january-9-2025-at-1100-a-m-est\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuroone-announces-virtual-investor-webinar-on-january-9-2025-at-1100-a-m-est\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyNjE0MyM2Njc3NTQ0IzUwMDExNDgzNA==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyNjE0MyM2Njc3NTQ0IzUwMDExNDgzNA=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuroone-announces-virtual-investor-webinar-on-january-9-2025-at-1100-a-m-est\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"NeuroOne\u00ae Announces Virtual Investor Webinar on January 9, 2025 at 11:00 a.m. EST"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/797701","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=797701"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/797701\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=797701"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=797701"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=797701"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}